Summary
In this paper we investigated the role played by human immuno-deficiency virus type 1 (HIV-1) in the pathogenesis of peripheral blood (PB) cytopenias of AIDS patients. The in vitro growth of PB granulocyte/macrophage progenitors (CFU-GM) was investigated in 45 HIV-1 seropositive (+) individuals at different stages of the disease. The number of circulating CFU-GM was significantly (p<0.01) lower in AIDS patients (stages WR V-VI) than in HIV-1(+) asymptomatic individuals (stages WR I-II). Moreover, the presence of gag p 24 in the plasma and/or viral isolation from PB mononuclear cells of HIV-1(+) individuals was inversely correlated (p<0.01) with the number of circulating CFU-GM, irrespectively with the stage of the disease. Viral isolates obtained from one asymptomatic and four symptomatic HIV-1(+) individuals were tested on the in vitro growth of normal hematopoietic progenitor (CD34+) cells, purified from PB of healthy donors. All the different viral isolates showed a dose-dependent inhibition of CD34+ cells, in the absence of either productive or latent infection. This suppressive effect was completely reversed by prein-cubating the different viral isolates with a polyclonal anti-gp 120 antibody before adding to normal CD34+ cells. These findings suggest a direct involvement of active viral replication products in the progressive impairment of hematopoiesis, characteristic of HIV-1(+) individuals in spite of the lack of a productive or latent infection of CD34+ hematopoietic progenitors.
Similar content being viewed by others
References
Andrews RG, Singer JW, Bernstein ID (1986) Monoclonal antibody 12-8 recognizes a 115 kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 67: 842–848
Ameisen JC, Capron A (1991) Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today 12: 102–110
Bagnara GP, Zauli G, Giovannini M, Re MC, Furlini G, La Placa M (1990) Early loss of circulating hemopoietic progenitors in HIV-1 infected subjects. Exp Hematol 18: 426–430
Bagnara GP, Zauli G, Re MC, Furlini G, Giovannini M, Brizzi MF, La Placa M (1991) Impaired GM-CSF production by cultured light density mononuclear cells and T lymphocytes correlates with the number of circulating CFU-GM in HIV-1 seropositive subjects. Int J Cell Clon 9: 239–250
Carlo Stella C, Ganser A, Hoelzer D (1987) Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome. J Clin Invest 80: 286–293
Davis BR, Marx JC, Johnson CE (1991) Absent or rare HIV infection of bone marrow stem/progenitor cells in vivo. J Virol 65: 1985–1990
Folks TM (1986) Biological and biochemical characterization of a cloned Leu-3-cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med 164: 280–290
Folks TM, Kessler SW, Orenstein JM, Justment JS, Laffee E, Fauci AS (1988) Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Science 242: 919–922
Folks TM (1991) Human immunodeficiency virus in bone marrow: still more questions than answers. Blood 77: 1625–1626
Kitano K, Abboud CN, Ryan DH, Quan SG, Baldwin GC, Golde DW (1991) Macrophage-active colony-stimulating factors enhance human immunodeficiency virus type 1 infection in bone marrow stem cells. Blood 77: 1699–1706
Lake JP, Lee S, Spira S (1984) Bone marrow findings in AIDS patients. Am J Clin Pathol 81: 799–800
Leiderman IZ, Greenberg ML, Adelsberg BR, Siegal F (1987) A glycoprotein inhibitor of in vitro granulopoiesis associated with AIDS. Blood 70: 1267–1272
Lotem J, Sachs L (1990) Selective regulation of the activity of different hematopoietic regulatory proteins by transforming growth factor β1 in normal and leukemic myeloid cells. Blood 76: 1315–1322
Molina JM, Scadden DT, Sakaguchi M, Fuller B, Woon A, Groopman JE (1990) Lack of evidence for infection of or effect on growth of hematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus. Blood 76: 2476–2482
Ou CY, Kwok S, Mitchell SW, Mack DH, Sninsky JJ, Krebs JW, Feorino P, Warfield D, Schochetman G (1988) DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 239: 205–297
Murphy MF, Metcalfe P, Waters AH (1987) Incidence and mechanisms of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol 66: 337–340
Paul DA, Falk LA, Kessler HA, Chase RM, Blaauw B, Chudwin DS, Landay AL (1987) Correlation of serum HIV antigen and antibody with clinical status in HIV-infected patients. J Med Virol 22: 357–363
Re MC, Furlini G, La Placa M (1989) Rapid detection of HIV-1 in clinical samples by co-culture with heat-shocked cells. J Virol Methods 26: 313–318
Re MC, Zauli G, Furlini G, Giovannini M, La Placa M (1991) HIV-1 infection and hematological picture. Microbiologica 14: 165–176
Scadden DT, Zon LI, Groopman JE (1989) Pathophysiology and management of HIV associated hematologic disorders. Blood 4: 1455–1463
Scharft SJ, Horn GT, Erlich HA (1986) Direct cloning and sequence analysis of enzymatically amplified genomic sequences. Science 233: 1076–1078
Spivak JL, Bender BS, Quinn TC (1984) Hematological abnormalities in AIDS. Am J Med 77: 224–228
Steinberg HN, Crumpacker CS, Chatis PA (1991) In vitro suppression of normal bone marrow progenitor cells by human immunodeficiency virus. J Virol 65: 1765–1769
Strauss LC, Bowley SD, La Russa VF, Sharkis SS, Stuart RK, Civin CI. Antigen analysis of hematopoiesis (1986) Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp Hematol 14: 878–886
Treacy M, Lai I, Costello C, Clark A (1987) Peripheral blood an bone marrow abnormalities in patients with HIV related diseases. Br J Haematol 65: 289–294
Völkers B, Ganser A, Carlo Stella C, Hoelzer D (1987) Decrease of in vitro colon formation of the hematopoietic progenitor cells CFU-GEMM, CFU-MK, BFU-E and CFU-GM in acquired immunodeficiency syndrome. In: Najiman A, Guion M, Gorin NC, Mery JY (eds) The inhibition of hematopoiesis. Edition Inserm, John Libbey, Paris, pp 331–334
Von Laer D, Hufert FT, Fenner TE, Schwander S, Dietrich M, Scmitz H, Kern P (1990) CD34+ hemaotpoietic progenitor cells are not a major reservoir of the human immunodeficiency virus. Blood 76: 1281–1286
Geissler RG, Ottmann OG, Kojouharoff G, Reutzel P, Eder M, Hoelzer D, Ganser A (1992) Influence of human recombinant inteferon-gamma on bone marrow progenitor cells of HIV-positive individuals. AIDS Res Hum Retroviruses 8: 521–525
Zauli G, Re MC, Furlini G, Giovannini M, La Placa M (1991) Evidence for an HIV-1 mediated suppression of in vitro growth of enriched (CD34+) hematopoietic progenitors. J AIDS 4: 1251–1253
Zauli G, Re MC, Visani G, Furlini G, La Placa M (1992) Inhibitory effect of HIV-1 envelope glycoproteins gp 120 and gp 160 on the in vitro growth of enriched (CD34+) hematopoietic progenitor cells. Arch Virol 122: 271–280
Stanle SK, Kessler SW, Justement JS, Schnittman SM, Greenhouse JJ, Brown CC, Musongela L, Musey K, Kapita B, Fauci AS (1992) CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals. J Immunol 149: 689–697
Zon LI, Arkin C, Groopman JE (1987) Hematologic manifestations of the human immunodeficiency virus (HIV). Br J Haematol 66: 251–256
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Re, M.C., Zauli, G., Furlini, G. et al. The impaired number of circulating granulocyte/macrophage progenitors (CFU-GM) in human immunodeficiency virus-type 1 infected subjects correlates with an active HIV-1 replication. Archives of Virology 129, 53–64 (1993). https://doi.org/10.1007/BF01316884
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01316884